Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population

Breast Cancer Research and Treatment

Volumn 110, Issue 3, 2008, Pages 543-545

  González Hormazábal, Patricio ^a   Castro, Víctor G ^a   Blanco, Rafael ^a   Gómez, Fernando ^b   Peralta, Octavio ^a   Waugh, Enrique ^c   Bravo, Teresa ^b   Reyes, Jose M ^d   Jara, Lilian ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b Corporación Nacional del Cáncer ^*  (Chile)

^c CLÍNICA SANTA MARÍA   (Chile)

^d CLÍNICA LAS CONDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; CHECKPOINT KINASE 2; GENOMIC DNA;

ALLELE; BREAST CANCER; CANCER SUSCEPTIBILITY; CHROMOSOME 22; DNA DAMAGE; DNA EXTRACTION; FAMILIAL CANCER; GENE DELETION; GENE MUTATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HUMAN; LETTER; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SOUTH AMERICA;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHILE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PROTEIN-SERINE-THREONINE KINASES; SOUTH AMERICA;

EID: 46949109347     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-007-9743-0     Document Type: Letter

References (27)

1. Nathanson KL, Weber BL (2001) 'Other' breast cancer susceptibility genes: searching for more holy grail. Hum Molec Genet 10:715-720
2. Nevanlinna H, Bartek J (2006) The CHEK2 gene and inherited breast cancer susceptibility. Oncogene 25:5912-5919
3. Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JGM, Hoogerbrugge N, Ligtenberg MJL, van Asperen CJ, Vasen HFA, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P (2003) The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families. Cancer Res 63:8153-8157
4. Meijers-Heijboer H, van den Ouweland A, Klijn J, Wasielewski M, de Snoo A, Oldenburg R, Hollestelle A, Houben M, Crepin E, van Veghel-Plandsoen M, Elstrodt F, van Duijn C, Bartels C, Meijers C, Schutte M, McGuffog L, Thompson D, Easton DF, Sodha N, Seal S, Barfoot R, Mangion J, Chang-Claude J, Eccles D, Eeles R, Evans DG, Houlston R, Murday V, Narod S, Peretz T, Peto J, Phelan C, Zhang HX, Szabo C, Devilee P, Goldgar D, Futreal PA, Nathanson KL, Weber BL, Rahman N, Stratton MR (2002) Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 31:55-59
5. CHEK2 Breast Cancer Case-Control Consortium (2004) CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175-1182
6. Vahteristo P, Bartkova J, Eerola H, Syrjakoski K, Ojala S, Kilpivaara O, Tamminen A, Kononen J, Aittomaki K, Heikkila P, Holli K, Blomqvist C, Bartek J, Kallioniemi OP, Nevanlinna H (2002) A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 71:432-438
7. Weischer M, Bojesen SE, Tybjaerg-Hansen A, Axelsson CK, Nordestgaard BG (2007) Increased risk of breast cancer associated with CHEK2*1100delC. J Clin Oncol 25:57-63
8. Chekmariova EV SA, Buslov KG, Iyevleva AG, Ulibina YM, Rozanov ME, Mitiushkina NVTA, Matsko DE, Voskresenskiy DA, Chagunava OL, Devilee P, Cornelisse CSV, Imyanitov EN (2006) CHEK2 1100delC mutation is frequent among Russian breast cancer patients. Breast Cancer Res Treat 100:99-102
9. Meijers-Heijboer H, Wijnen J, Vasen H, Wasielewski M, Wagner A, Hollestelle A, Elstrodt F, van den Bos R, de Snoo A, Fat GTA, Brekelmans C, Jagmohan S, Franken P, Verkuijlen P, van den Ouweland A, Chapman P, Tops C, Moslein G, Burn J, Lynch H, Klijn J, Fodde R, Schutte M (2003) The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet 72:1308-1314
10. Dufault MR, Betz B, Wappenschmidt B, Hofmann W, Bandick K, Golla A, Pietschmann A, Nestle-Kramling C, Rhiem K, Huttner C, Von Lindern C, Dall P, Kiechle M, Untch M, Jonat W, Meindl A, Scherneck S, Niederacher D, Schmutzler RK, Arnold N (2004) Limited relevance of the CHEK2 gene in hereditary breast cancer. Int J Cancer 110:320-325
11. Rashid MU, Jakubowska A, Justenhoven C, Harth V, Pesch B, Baisch C, Pierl CB, Bruning T, Ko Y, Benner A, Wichmann HE, Rauch H, Hamann U (2005) German populations with infrequent CHEK2*1100delC and minor associations with early-onset and familial breast cancer. Eur J Cancer 41:2896-2903
12. Kleibl Z, Novotny J, Bezdickova D, Malik R, Kleiblova P, Foretova L, Petruzelka L, Ilencikova D, Cinek P, Pohlreich P (2005) The CHEK2 c.1100delC germline mutation rarely contributes to breast cancer development in the Czech Republic. Breast Cancer Res Treat 90:165-167
13. Martínez-Bouzas C BE, Guerra I, Gorostiaga J, Mendizabal JL, De-Pablo JL G-AE, Sanz-Parra A, Tejada MI (2007) CHEK2 1100delC is present in familial breast cancer cases of the Basque Country. Breast Cancer Res Treat 103:111-113
14. Osorio A, Rodriguez-Lopez R, Diez O, de la Hoya M, Martinez JI, Vega A, Esteban-Cardenosa E, Alonso C, Caldes T, Benitez J (2004) The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer 108:54-56
15. Caligo MA, Agata S, Aceto G, Crucianelli R, Manoukian S, Peissel B, Scaini MC, Sensi E, Veschi S, Cama A, Radice P, Viel A, D'Andrea E, Montagna M (2004) The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in Italy. Hum Mutat 24:100-101
16. Sodha N, Houlston RS, Bullock S, Yuille MA, Chu C, Turner G, Eeles RA (2002) Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome. Hum Mutat 20:460-462
17. Mateus-Pereira LH, Sigurdson AJ, Doody MM, Pineda MA, Alexander BH, Greene MH, Struewing JP (2004) CHEK2: 1100delC and female breast cancer in the United States. Int J Cancer 112:541-543
18. Offit KPH, Kirchhoff T, Kolachana P, Rapaport B, Gregersen P, Johnson S, Yossepowitch OHH, Satagopan J, Robson M, Scheuer L, Nafa K, Ellis N (2003) Frequency of CHEK2*1100delC in New York breast cancer cases and controls. BMC Med Genet 4:1
19. Bernstein JL, Teraoka SN, John EM, Andrulis IL, Knight JA, Lapinski R, Olson ER, Wolitzer AL, Seminara D, Whittemore AS, Concannon P (2006) The CHEK2*1100delC allelic variant and risk of breast cancer: Screening results from the breast cancer family registry. Cancer Epidemiol Biomark Prev 15:348-352
20. Jekimovs CR, Chen X, Arnold J, Gatei M, Richard DJ, Spurdle AB, Khanna KK, Chenevix-Trench G (2005) Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals. Br J Cancer 92:784-790
21. Jara L, Ampuero S, Santibanez E, Seccia L, Rodriguez J, Bustamante M, Martinez V, Catenaccio A, Lay-Son G, Blanco R, Reyes JM (2006) BRCA1 and BRCA2 mutations in a South American population. Cancer Genet Cytogenet 166:36-45
22. Schutte M, Seal S, Barfoot R, Meijers-Heijboer H, Wasielewski M, Evans DG, Eccles D, Meijers C, Lohman F, Klijn J, van den Ouweland A, Futreal PA, Nathanson KL, Weber BL, Easton DF, Stratton MR, Rahman N (2003) Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility. Am J Hum Genet 72:1023-1028
23. Cruz-Coke R (1976) Origen y evolución étnica de la población chilena. Rev Med Chile 101:365-368
24. Valenzuela CY, Harb Z (1977) Socioeconomic assortative mating in Santiago, Chile: As demonstrated using stochastic matrices of mother-child relationships applied to ABO blood groups. Soc Biol 24:225-233
25. Valenzuela CY, Acuña M, Harb Z (1987) Gradiente sociogenético en la población chilena. Rev Med Chile 115:295-299
26. Valenzuela CY (1988) On Sociogenetic Clines. Ethol Sociobiol 9:259-268
27. Frenguelli J (1963) The present status of the theories concerning primitive man in Argentina. In: Steward JH (ed) Handbook of South American Indians, vol. 6. Cooper Square Publisher, Inc, New York, pp 11-17